Spectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss

Trans Am Ophthalmol Soc. 2009 Dec:107:28-33.

Abstract

Purpose: To describe spectral-domain optical coherence tomography (SD-OCT) and adaptive optics (AO) imaging in hydroxychloroquine retinal toxicity.

Methods: Two patients with long-term hydroxychloroquine use, subtle perifoveal ophthalmoscopic pigmentary changes, and bilateral perifoveal defects on automated Humphrey visual field (HVF) 10-2 perimetry were imaged using SD-OCT and AO.

Results: SD-OCT images demonstrated loss of photoreceptor inner segment/outer segment (IS/OS) junction and a downward "sink-hole" displacement of inner retinal structures in areas of hydroxychloroquine toxicity corresponding to HVF 10-2 defects and ophthalmoscopic clinical examination findings. SD-OCT irregularities in the IS/OS junction were also seen in areas not detected on HVF 10-2. AO images showed disruption of the cone photoreceptor mosaic in areas corresponding to HVF 10-2 defects and SD-OCT IS/OS junction abnormalities. Additionally, irregularities in the cone photoreceptor density and mosaic were seen in areas with normal HVF 10-2 and SD-OCT findings.

Conclusions: SD-OCT and AO detected abnormalities that correlate topographically with visual field loss from hydroxychloroquine toxicity as demonstrated by HVF 10-2 and may be useful in the detection of subclinical abnormalities that precede symptoms or objective visual field loss.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Female
  • Fluorescein Angiography
  • Humans
  • Hydroxychloroquine / adverse effects*
  • Hydroxychloroquine / therapeutic use
  • Lupus Erythematosus, Systemic / drug therapy
  • Middle Aged
  • Ophthalmoscopy
  • Optics and Photonics / methods*
  • Retina / drug effects
  • Retina / pathology
  • Retinal Cone Photoreceptor Cells / pathology
  • Retinal Diseases / chemically induced*
  • Retinal Diseases / complications
  • Retinal Diseases / diagnosis*
  • Retinal Diseases / metabolism
  • Retinal Pigments / metabolism
  • Sjogren's Syndrome / drug therapy
  • Tomography, Optical Coherence / methods*
  • Vision Disorders / etiology*
  • Visual Field Tests
  • Visual Fields

Substances

  • Antirheumatic Agents
  • Retinal Pigments
  • Hydroxychloroquine